The global hemodialysis market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market is driven by factors such as increasing prevalence of chronic kidney disease and rising incidence of drug overdose cases.
Activated carbon adsorption segment accounted for the largest share in the global hemodialysis market in 2018, with 76% share and is expected to grow at a CAGR of 6.2% during the forecast period, from 2021 to 2030. Resin adsorption segment accounted for 24% share in 2018 and is expected to grow at a CAGR of 4%. Resin adsorption takes up the largest share of the market segmentation due to its high efficiency in removing toxins from blood plasma and low cost per unit volume compared with other types such as activated carbon adsorption or membrane filtration methods.
-The market for hemoperfusion is expected to grow at a CAGR of 5.5% from 2017 to 2025.
-Hemoperfusion is used in the treatment of acute renal failure, liver failure, and other conditions that cause accumulation of toxins in the blood.
-Hemoperfusion can be used as an alternative treatment for patients who are not eligible for kidney transplantation or dialysis.
Industry Growth Insights published a new data on “Hemoperfusion Market”. The research report is titled “Hemoperfusion Market research by Types (Activated Carbon Adsorption, Resin Adsorption, Resin Adsorption takes up the largest share of the market segmentation of 76%, and is the fastest growing segment), By Applications (Hepatic Encephalopathy, Certain Autoimmune Diseases, Drug Overdose, Specific Intoxications, Others), By Players/Companies Jafron Biomedical, Baxter (Gambro), Asahi-Kasei, Biosun Medical, Kaneka, Toray Medical, Cytosorbents, Aier, Zibo Kangbei”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Hemoperfusion Market Research Report
By Type
Activated Carbon Adsorption, Resin Adsorption, Resin Adsorption takes up the largest share of the market segmentation of 76%, and is the fastest growing segment
By Application
Hepatic Encephalopathy, Certain Autoimmune Diseases, Drug Overdose, Specific Intoxications, Others
By Companies
Jafron Biomedical, Baxter (Gambro), Asahi-Kasei, Biosun Medical, Kaneka, Toray Medical, Cytosorbents, Aier, Zibo Kangbei
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
244
Number of Tables & Figures
171
Customization Available
Yes, the report can be customized as per your need.
Global Hemoperfusion Market Report Segments:
The global Hemoperfusion market is segmented on the basis of:
Types
Activated Carbon Adsorption, Resin Adsorption, Resin Adsorption takes up the largest share of the market segmentation of 76%, and is the fastest growing segment
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hepatic Encephalopathy, Certain Autoimmune Diseases, Drug Overdose, Specific Intoxications, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Jafron Biomedical
- Baxter (Gambro)
- Asahi-Kasei
- Biosun Medical
- Kaneka
- Toray Medical
- Cytosorbents
- Aier
- Zibo Kangbei
Highlights of The Hemoperfusion Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Activated Carbon Adsorption
- Resin Adsorption
- Resin Adsorption takes up the largest share of the market segmentation of 76%, and is the fastest growing segment
- By Application:
- Hepatic Encephalopathy
- Certain Autoimmune Diseases
- Drug Overdose
- Specific Intoxications
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Hemoperfusion Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Hemoperfusion is a medical procedure that uses high-pressure air to help remove blood from the body.
Some of the key players operating in the hemoperfusion market are Jafron Biomedical, Baxter (Gambro), Asahi-Kasei, Biosun Medical, Kaneka, Toray Medical, Cytosorbents, Aier, Zibo Kangbei.
The hemoperfusion market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Hemoperfusion Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Hemoperfusion Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Hemoperfusion Market - Supply Chain
4.5. Global Hemoperfusion Market Forecast
4.5.1. Hemoperfusion Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Hemoperfusion Market Size (000 Units) and Y-o-Y Growth
4.5.3. Hemoperfusion Market Absolute $ Opportunity
5. Global Hemoperfusion Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Hemoperfusion Market Size and Volume Forecast by Type
5.3.1. Activated Carbon Adsorption
5.3.2. Resin Adsorption
5.3.3. Resin Adsorption takes up the largest share of the market segmentation of 76%, and is the fastest growing segment
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Hemoperfusion Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Hemoperfusion Market Size and Volume Forecast by Application
6.3.1. Hepatic Encephalopathy
6.3.2. Certain Autoimmune Diseases
6.3.3. Drug Overdose
6.3.4. Specific Intoxications
6.3.5. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Hemoperfusion Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Hemoperfusion Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Hemoperfusion Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Hemoperfusion Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Hemoperfusion Demand Share Forecast, 2019-2026
9. North America Hemoperfusion Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Hemoperfusion Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Hemoperfusion Market Size and Volume Forecast by Application
9.4.1. Hepatic Encephalopathy
9.4.2. Certain Autoimmune Diseases
9.4.3. Drug Overdose
9.4.4. Specific Intoxications
9.4.5. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Hemoperfusion Market Size and Volume Forecast by Type
9.7.1. Activated Carbon Adsorption
9.7.2. Resin Adsorption
9.7.3. Resin Adsorption takes up the largest share of the market segmentation of 76%, and is the fastest growing segment
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Hemoperfusion Demand Share Forecast, 2019-2026
10. Latin America Hemoperfusion Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Hemoperfusion Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Hemoperfusion Market Size and Volume Forecast by Application
10.4.1. Hepatic Encephalopathy
10.4.2. Certain Autoimmune Diseases
10.4.3. Drug Overdose
10.4.4. Specific Intoxications
10.4.5. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Hemoperfusion Market Size and Volume Forecast by Type
10.7.1. Activated Carbon Adsorption
10.7.2. Resin Adsorption
10.7.3. Resin Adsorption takes up the largest share of the market segmentation of 76%, and is the fastest growing segment
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Hemoperfusion Demand Share Forecast, 2019-2026
11. Europe Hemoperfusion Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Hemoperfusion Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Hemoperfusion Market Size and Volume Forecast by Application
11.4.1. Hepatic Encephalopathy
11.4.2. Certain Autoimmune Diseases
11.4.3. Drug Overdose
11.4.4. Specific Intoxications
11.4.5. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Hemoperfusion Market Size and Volume Forecast by Type
11.7.1. Activated Carbon Adsorption
11.7.2. Resin Adsorption
11.7.3. Resin Adsorption takes up the largest share of the market segmentation of 76%, and is the fastest growing segment
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Hemoperfusion Demand Share, 2019-2026
12. Asia Pacific Hemoperfusion Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Hemoperfusion Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Hemoperfusion Market Size and Volume Forecast by Application
12.4.1. Hepatic Encephalopathy
12.4.2. Certain Autoimmune Diseases
12.4.3. Drug Overdose
12.4.4. Specific Intoxications
12.4.5. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Hemoperfusion Market Size and Volume Forecast by Type
12.7.1. Activated Carbon Adsorption
12.7.2. Resin Adsorption
12.7.3. Resin Adsorption takes up the largest share of the market segmentation of 76%, and is the fastest growing segment
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Hemoperfusion Demand Share, 2019-2026
13. Middle East & Africa Hemoperfusion Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Hemoperfusion Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Hemoperfusion Market Size and Volume Forecast by Application
13.4.1. Hepatic Encephalopathy
13.4.2. Certain Autoimmune Diseases
13.4.3. Drug Overdose
13.4.4. Specific Intoxications
13.4.5. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Hemoperfusion Market Size and Volume Forecast by Type
13.7.1. Activated Carbon Adsorption
13.7.2. Resin Adsorption
13.7.3. Resin Adsorption takes up the largest share of the market segmentation of 76%, and is the fastest growing segment
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Hemoperfusion Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Hemoperfusion Market: Market Share Analysis
14.2. Hemoperfusion Distributors and Customers
14.3. Hemoperfusion Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Jafron Biomedical
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Baxter (Gambro)
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Asahi-Kasei
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Biosun Medical
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Kaneka
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Toray Medical
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Cytosorbents
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Aier
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Zibo Kangbei
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
